Healthcare Brief Comoros: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Brief Comoros.

Press releases published on September 24, 2026

10 hours ago

Immuneering to Present at the ESMO Congress 2026

Indeterminate GlobeNewswire

10 hours ago

Kala Bio and Virotek Sign Letter of Intent with U.S. DNA Testing Platform to Resell Virotek's Suite of Genetic Testing Products

Indeterminate GlobeNewswire

10 hours ago

Profusa Announces Significant Progress Towards Lumee® Oxygen Platform CE Mark with ISO 13485 Certification Expected in Early October

Indeterminate GlobeNewswire

10 hours ago

Kraig Biocraft Laboratories Reaches Major Scientific Milestone with Completion of Functional and Living Atlas Gene Library

Indeterminate GlobeNewswire

10 hours ago

Coave Therapeutics to Present New Data on Wet AMD Gene Therapy Program at 26th Euretina Congress as it Advances towards the Clinic

Indeterminate GlobeNewswire

10 hours ago

Atavistik Bio Announces Strategic Research Collaboration with Roche to Discover and Develop Novel Allosteric Therapeutics

Indeterminate GlobeNewswire

10 hours ago

Medicenna Announces Oral Presentation of New Bizaxofusp Results in Recurrent Glioblastoma at the 2026 Society for Neuro-Oncology Annual Meeting

Indeterminate GlobeNewswire

10 hours ago

What CX Leaders Should Understand About Customer Support Outsourcing

Indeterminate GlobeNewswire

10 hours ago

Satellos Announces FDA Clearance of IND Application for Forazapadin in Facioscapulohumeral Muscular Dystrophy (FSHD) and a Partnership with FSHD Canada Foundation Providing Non-Dilutive Financing to Support Clinical Development

Indeterminate GlobeNewswire

10 hours ago

Vistagen Reports Positive Findings Supporting Fasedienol’s Potential in Very Severe Social Anxiety Disorder

Indeterminate GlobeNewswire

10 hours ago

Cullinan Therapeutics Highlights Fourth Quarter 2026 Milestones Across Immunology and Oncology T Cell Engager Portfolio

Indeterminate GlobeNewswire

10 hours ago

Ligand and AvenCell Therapeutics Enter Financing Agreement to Advance Pipeline of Next-Generation CAR-T Therapies for Up to $47 Million

Indeterminate GlobeNewswire

10 hours ago

PridCor Therapeutics Advances Phase 2 SHIELD Study of a Combination Antiviral Regimen for Long COVID Toward Enrollment

Indeterminate GlobeNewswire

10 hours ago

Mesoblast Receives FDA Approval for New Potency Assay to Release Commercial Ryoncil Product

Indeterminate GlobeNewswire

11 hours ago

Amesite Announces New Sales Win Under NurseMagic® Minimum Enterprise Pricing Model

Indeterminate GlobeNewswire

11 hours ago

Kyverna Therapeutics Reports Positive One-Year Data Demonstrating Durable Clinical Responses and Favorable Safety Profile for Miv-cel in Stiff Person Syndrome and Generalized Myasthenia Gravis

Indeterminate GlobeNewswire

11 hours ago

MediciNova Announces Completion of Last Patient, Last Visit in the Double-Blind Portion of the Phase 2b/3 COMBAT-ALS Trial of MN-166 (Ibudilast)

Indeterminate GlobeNewswire

11 hours ago

Biodesix Advances Two Complementary Approaches to Molecular Residual Disease (MRD) Monitoring

Indeterminate GlobeNewswire

11 hours ago

aTyr Pharma Announces Alignment with FDA on Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis

Indeterminate GlobeNewswire

12 hours ago

Adventure With a Purpose: A Race Against Blindness Unveils Adventure Package Fundraiser Valued at $350,000

Indeterminate GlobeNewswire